Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202502092 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Min Ji Byun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, 16419, Repu…. Hauptthemen laut MEDLINE: Neutrophils, Inflammation, Nanoparticles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare (MOHW), South Korea, NIMHD NIH HHS, National Institute on Minority Health and Health Disparities (NIMHD).
Abstract (Originalsprache)
Neutrophils, the most abundant leukocytes in human blood, play a critical role in the initial response to acute infection and injury. Activated neutrophils exert three primary effector functions: phagocytosis, degranulation of proteolytic enzymes into pericellular spaces, and generation of neutrophil extracellular traps (NETs). However, dysregulated neutrophil function can lead to tissue damage and inflammation, resulting in organ dysfunction that ultimately contributes to the progression of various diseases. Given the implication of neutrophils in the pathogenesis of diseases arising from chronic inflammation, exploring emerging therapies targeting these cells is critical for developing more effective treatment options. This review highlights nanotechnology‐based therapeutic strategies aimed at modulating neutrophil activity and NET formation, with a focus on nanoparticles (NPs) and hydrogels. NPs‐based delivery systems can regulate excessive neutrophil activity through targeted delivery of anti‐inflammatory drugs, alteration of gene expression, induction of cell death, or inhibition of neutrophil recruitment. Additionally, various nanotechnology‐based therapeutics can inhibit NET formation or degrade NETs following neutrophil activation. NPs can also be internalized by neutrophils and utilized as carriers, facilitating localized therapeutic delivery as neutrophils are recruited to inflammatory sites. The importance of targeting or harnessing neutrophils are explained and we discuss therapeutic strategies to control their activity, which may aid in designing future treatments for neutrophil‐mediated inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Institute for Cross-disciplinary Studies (ICS), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, 16419, Republic of Korea.
- Department of Intelligent Precision Healthcare Convergence, ICS, SKKU, Suwon, Gyeonggi-do, 16419, Republic of Korea.
- University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, HI, 96813, USA.
- Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, 96813, USA.
- Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Mānoa, Honolulu, HI, 96813, USA.
- Biomaterials Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
ORCID-Profile: Chun Gwon Park
Förderung
- Ministry of Health and Welfare (MOHW), South Korea
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities (NIMHD)
- Korea Institute of Science and Technology (KIST)
- Ministry of Science and ICT (MSIT), South Korea
Zitieren
APA
Byun, M. J., Nakasone, E. S., Shin, H. E., Lee, H., Park, J. C., Lee, W., Park, W., Park, C. G., Park, J., & Kim, S. N. (2025). Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502092
Vancouver
Byun MJ, Nakasone ES, Shin HE, Lee H, Park JC, Lee W, et al. Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202502092
BibTeX
@article{Byun2025,
author = {Byun, Min Ji and Nakasone, Elizabeth S and Shin, Ha Eun and Lee, Hyojin and Park, Jong-Chan and Lee, Wonhwa and Park, Wooram and Park, Chun Gwon and Park, Juwon and Kim, Se-Na},
title = {Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202502092}
}
EUVIMED